Aim of this study was to synthesize new inhibitors on the basis of active site of aspartic protease enzyme and to evaluate their intended biological activity. A3D model of an enzyme was generated via homology modeling and series of novel amide ligands were synthesized by using a short high yield process, subsequently, analyzed in-silico and in-vitro anti-leishmanial activities. Characterization and identification was accomplished via NMR (H1& C13), infrared and mass spectroscopic techniques. Among all compound (4) was found to show significant activity (IC50 58±0.01) against Leishmania major (L. major) species. Furthermore, docking studies confirmed the inhibition of a targeted enzyme that supported the interaction of potent compound (4) wi...
International audienceLeishmaniases are neglected parasitic diseases in spite of the major burden th...
<p>Visceral leishmaniasis caused by the protozoan <i>Leishmania donovan</i>i is the most severe form...
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatment...
Background and purpose: Leishmaniasis is one of the most important infectious diseases caused by dif...
Due to the lack of approved vaccines against human leishmaniasis and the limitations of the current ...
Leishmaniasis is a neglected tropical disease of major public health concern. Challenges with curren...
Leishmaniasis is a group of infectious diseases caused by Leishmania protozoa. The ineffectiveness, ...
Since many of the currently available antileishmanial treatments exhibit toxicity, low effectiveness...
<p>Targeting CAAX prenyl proteases of <i>Leishmania donovani</i> can be a good approach towards deve...
In this study, out of sixteen compounds, only thirteen compounds have shown hydrogen bonding with th...
Leishmaniasis is a widespread parasitic disease and is one of the major public health concerns in de...
Since many of the currently available antileishmanial treatments exhibit toxicity, low effectiveness...
Cofactor-independent phosphoglycerate mutase has been proposed as a therapeutic target for the treat...
Leishmaniases are neglected parasitic diseases in spite of the major burden they inflict on public h...
Abstract Objective Present in silico study was carried out to explore the mode of inhibition of Leis...
International audienceLeishmaniases are neglected parasitic diseases in spite of the major burden th...
<p>Visceral leishmaniasis caused by the protozoan <i>Leishmania donovan</i>i is the most severe form...
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatment...
Background and purpose: Leishmaniasis is one of the most important infectious diseases caused by dif...
Due to the lack of approved vaccines against human leishmaniasis and the limitations of the current ...
Leishmaniasis is a neglected tropical disease of major public health concern. Challenges with curren...
Leishmaniasis is a group of infectious diseases caused by Leishmania protozoa. The ineffectiveness, ...
Since many of the currently available antileishmanial treatments exhibit toxicity, low effectiveness...
<p>Targeting CAAX prenyl proteases of <i>Leishmania donovani</i> can be a good approach towards deve...
In this study, out of sixteen compounds, only thirteen compounds have shown hydrogen bonding with th...
Leishmaniasis is a widespread parasitic disease and is one of the major public health concerns in de...
Since many of the currently available antileishmanial treatments exhibit toxicity, low effectiveness...
Cofactor-independent phosphoglycerate mutase has been proposed as a therapeutic target for the treat...
Leishmaniases are neglected parasitic diseases in spite of the major burden they inflict on public h...
Abstract Objective Present in silico study was carried out to explore the mode of inhibition of Leis...
International audienceLeishmaniases are neglected parasitic diseases in spite of the major burden th...
<p>Visceral leishmaniasis caused by the protozoan <i>Leishmania donovan</i>i is the most severe form...
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatment...